{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:15:44Z","timestamp":1762157744820,"version":"3.37.3"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural science Foundation of China","doi-asserted-by":"crossref","award":["81373415","21272277"],"award-info":[{"award-number":["81373415","21272277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ejphar.2016.04.023","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T06:31:05Z","timestamp":1460529065000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating antithrombotic activity of HY023016 on rat hypercoagulable model"],"prefix":"10.1016","volume":"781","author":[{"given":"Qiu-fang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Zhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Rui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Xing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Zhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Dou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Gen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Qing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejphar.2016.04.023_bib1","first-page":"756","article-title":"Venous thromboembolism (VTE) in Europe.The number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ejphar.2016.04.023_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/blood.V88.1.146.146","article-title":"Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta (2)-integrin CD11b\/CD18","volume":"88","author":"Diacovo","year":"1996","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejphar.2016.04.023_bib3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1538-7836.2006.02152.x","article-title":"Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies","volume":"4","author":"Eliasson","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.ejphar.2016.04.023_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejim.2007.10.019","article-title":"Venous and arterial thrombosis: different sides of the same coin?","volume":"19","author":"Franchini","year":"2008","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2016.04.023_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.thromres.2012.11.028","article-title":"Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state","volume":"131","author":"Ghasemzadeh","year":"2013","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2016.04.023_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beha.2012.06.007","article-title":"Venous thromboembolism: epidemiology and magnitude of the problem","volume":"25","author":"Goldhaber","year":"2012","journal-title":"Best. Pract. Res. Clin. Haematol."},{"issue":"3","key":"10.1016\/j.ejphar.2016.04.023_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0038-1642436","article-title":"Dx-9065a, a new synthetic, potent anticoagulant and selective inhibitor for Factor-Xa","volume":"71","author":"Hara","year":"1994","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.ejphar.2016.04.023_bib8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.910.910","article-title":"Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US","volume":"106","author":"Heit","year":"2005","journal-title":"Blood"},{"issue":"6667","key":"10.1016\/j.ejphar.2016.04.023_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejphar.2016.04.023_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct thrombin inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.04.023_bib11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2353\/ajpath.2008.070633","article-title":"CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury","volume":"172","author":"Li","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.ejphar.2016.04.023_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2003.08.026","article-title":"Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry","volume":"111","author":"Li","year":"2003","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2016.04.023_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.thromres.2013.03.004","article-title":"Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models","volume":"131","author":"Li","year":"2013","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2016.04.023_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pharmthera.2010.12.007","article-title":"The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism","volume":"130","author":"Mavrakanas","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.ejphar.2016.04.023_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa022157","article-title":"An association between atherosclerosis and venous thrombosis","volume":"348","author":"Prandoni","year":"2003","journal-title":"N Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2016.04.023_bib16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.thromres.2010.08.018","article-title":"An experimental model to study isolated effects of thrombin in vivo","volume":"126","author":"Siller-Matula","year":"2010","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2016.04.023_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1084\/jem.192.2.193","article-title":"Platelet glycoprotein Ib alpha is a counter receptor for the leukocyte integrin Mac-1 (CD11b\/CD18)","volume":"192","author":"Simon","year":"2000","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2016.04.023_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.thromres.2012.01.002","article-title":"Effect of the factor Xa inhibitor rivaroxaban on arterial thrombosis in wild-type and apolipoprotein E-deficient mice","volume":"130","author":"Wagner","year":"2012","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2016.04.023_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2001.02981.x","article-title":"Investigation and management of heritable thrombophilia","volume":"114","author":"Walker","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.ejphar.2016.04.023_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1172\/JCI0214151","article-title":"P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow","volume":"109","author":"Xia","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.ejphar.2016.04.023_bib21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.fitote.2011.08.009","article-title":"In vitro metabolism in Sprague-Dawley rat liver microsomes of forsythoside A in different compositions of Shuang-Huang-Lian","volume":"82","author":"Zhou","year":"2011","journal-title":"Fitoterapia"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916302382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916302382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T18:35:22Z","timestamp":1655490922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916302382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":21,"alternative-id":["S0014299916302382"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.04.023","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating antithrombotic activity of HY023016 on rat hypercoagulable model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}